Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07671677 · ClinicalTrials.gov registry record
BOdygUardian MOnitoriNg for ReCurrencE of AF
A clinical trial, sponsored by Heart Rhythm Clinical and Research Solutions.
- Not yet
- Registry status
- 100
- Enrollment target
NCT07671677 is a clinical trial that has not yet begun recruiting, run by Heart Rhythm Clinical and Research Solutions. The registered enrollment target is 100 participants.
The verdict
NCT07671677 has not yet begun recruiting, sponsored by Heart Rhythm Clinical and Research Solutions.
- NOT YET RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
The DISRUPT-AF Registry is an observational, prospective, multi-center, non-randomized, real-world registry designed to obtain clinical experience with the FARAPULSE Pulsed Field Ablation (PFA) System for the treatment of atrial fibrillation (AF). The data collected for this study will be from a subset of patients enrolled in the pre-existing DISRUPT AF Registry. Additionally, patients in the Full Monitoring Arm may be approached and consented for participation in BOUNCE-AF. The post-ablation monitoring timepoints will reflect the site's standard of care (SOC), which is typically at 6- and 12-months post-ablation. Consented patients will complete 1 survey about their experience after wearing the BodyGuardian at 6-months. Clinical staff that consent will also complete a survey on their experience using BodyGuardian. The clinical staff include those that either directly prescribe the monitor, place the monitor on the patient and/or train the patient on the use of the monitor, or those involved in reviewing the data.
Interventions
- DEVICE BodyGuardian
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-07 |
| Est. Completion | 2028-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07671677
The ClinicalTrials.gov registry entry for NCT07671677 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Heart Rhythm Clinical and Research Solutions, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BodyGuardian is the first listed.
NCT07671677 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07671677 about?
NCT07671677 is a clinical study titled "BOdygUardian MOnitoriNg for ReCurrencE of AF". The DISRUPT-AF Registry is an observational, prospective, multi-center, non-randomized, real-world registry designed to obtain clinical experience with the FARAPULSE Pulsed Field Ablation (PFA) System for the treatment of atrial fibrillation (AF). The data collected for this study will be from a sub...
What is the current status of trial NCT07671677?
This trial is currently not yet recruiting. The enrollment target is 100 participants. The study started on 2026-07. Estimated completion is 2028-04.
What interventions are being tested in trial NCT07671677?
The interventions under investigation include: BodyGuardian (DEVICE).
Who is sponsoring clinical trial NCT07671677?
This trial is sponsored by Heart Rhythm Clinical and Research Solutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.